709 related articles for article (PubMed ID: 15883628)
1. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
Jaglal SB; Weller I; Mamdani M; Hawker G; Kreder H; Jaakkimainen L; Adachi JD
J Bone Miner Res; 2005 Jun; 20(6):898-905. PubMed ID: 15883628
[TBL] [Abstract][Full Text] [Related]
2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
3. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
Smith MD; Ross W; Ahern MJ
J Rheumatol; 2001 Nov; 28(11):2504-8. PubMed ID: 11708425
[TBL] [Abstract][Full Text] [Related]
4. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
[TBL] [Abstract][Full Text] [Related]
5. Effect of total hip bone area on osteoporosis diagnosis and fractures.
Leslie WD; Tsang JF; Lix LM
J Bone Miner Res; 2008 Sep; 23(9):1468-76. PubMed ID: 18442317
[TBL] [Abstract][Full Text] [Related]
6. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
Hodsman AB; Leslie WD; Tsang JF; Gamble GD
Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
[TBL] [Abstract][Full Text] [Related]
7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
9. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
Leslie WD; Tsang JF; Lix LM
Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
[TBL] [Abstract][Full Text] [Related]
10. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures.
Cauley JA; Zmuda JM; Yaffe K; Kuller LH; Ferrell RE; Wisniewski SR; Cummings SR
J Bone Miner Res; 1999 Jul; 14(7):1175-81. PubMed ID: 10404018
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
[TBL] [Abstract][Full Text] [Related]
14. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
Reid IR; Gamble GD; Grey AB; Black DM; Ensrud KE; Browner WS; Bauer DC
J Bone Miner Res; 2005 Apr; 20(4):613-8. PubMed ID: 15765180
[TBL] [Abstract][Full Text] [Related]
15. Bone density and fracture risk in men.
Melton LJ; Atkinson EJ; O'Connor MK; O'Fallon WM; Riggs BL
J Bone Miner Res; 1998 Dec; 13(12):1915-23. PubMed ID: 9844110
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis and fracture risk in women of different ethnic groups.
Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
[TBL] [Abstract][Full Text] [Related]
17. Developments of the incidence of osteoporosis in The Netherlands: a PHARMO study.
Goettsch WG; de Jong RB; Kramarz P; Herings RM
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):166-72. PubMed ID: 16700086
[TBL] [Abstract][Full Text] [Related]
18. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men.
Haentjens P; Johnell O; Kanis JA; Bouillon R; Cooper C; Lamraski G; Vanderschueren D; Kaufman JM; Boonen S;
J Bone Miner Res; 2004 Dec; 19(12):1933-44. PubMed ID: 15537435
[TBL] [Abstract][Full Text] [Related]
19. Nulliparity and fracture risk in older women: the study of osteoporotic fractures.
Hillier TA; Rizzo JH; Pedula KL; Stone KL; Cauley JA; Bauer DC; Cummings SR
J Bone Miner Res; 2003 May; 18(5):893-9. PubMed ID: 12733729
[TBL] [Abstract][Full Text] [Related]
20. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
